US Stock MarketDetailed Quotes

ABCL AbCellera Biologics

Watchlist
  • 2.760
  • +0.040+1.47%
Close Nov 22 16:00 ET
  • 2.870
  • +0.110+3.99%
Pre 05:35 ET
815.21MMarket Cap-4524P/E (TTM)

AbCellera Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AbCellera Biologics Q3 2024 Earnings Date

Currency：USDNov 4, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
8.01M
6.51M
-1.51M
Miss Est.
+21.45%
-1.39%
-18.81%
EPS
-0.13
-0.17
-0.04
Miss Est.
-30.03%
-70.00%
-30.87%
Analyst Rating
Strong Buy

Nov 22, 2024

AbCellera Biologics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 11.812M--
--2024/Q4-- / 7.579M--
Nov 4, 20242024/Q36.507M / 8.015M--
Aug 6, 20242024/Q27.323M / 10.015M--
May 7, 20242024/Q19.954M / 11.005M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 11.812M--
--2024/Q4-- / 7.579M--
Nov 4, 20242024/Q36.507M / 8.015M--
Aug 6, 20242024/Q27.323M / 10.015M--
May 7, 20242024/Q19.954M / 11.005M--

Unlock Free Earnings Estimates

AbCellera Biologics Earnings Reports

  • AbCellera Biologics | 10-Q: Q3 2024 Earnings Report

    Nov 4 16:39 ET

  • AbCellera Biologics | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:59 ET

  • AbCellera Biologics | 10-Q: Q1 2024 Earnings Report

    May 7 16:54 ET

  • AbCellera Biologics | 10-K: FY2023 Annual Report

    Feb 20 22:18 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 22, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data